News of Note—Seqirus, Fujifilm and more

A Fujifilm Diosynth partnership and flu vaccine effectiveness are among this week's news of note.

> Seqirus executives expect to break even this year and report that the flu vaccine company is on track to profitability. Sky News story

> Fujifilm Diosynth and Texas A&M University are collaborating as a Center for Innovation in Advanced Development and Manufacturing. Bryan-College Station Eagle story

> Flu vaccines were 48% effective overall last year, according to a study published in The New England Journal of Medicine. Study

> Former GlaxoSmithKline vaccine head Moncef Slaoui resigned from Intellia's board. Boston Business Journal story

> Vaxess, a preclinical vaccine biotech, picked up former Sanofi Pasteur head Wayne Pisano for its advisory board. Release